$36,755
Former Officer and COO
2023
$37k
--
Former Officer and COO at Foundation for Angelman Syndrome Therapeutics
Fiscal year ended December 31, 2023. Published on January 25, 2026.
Total compensation
Maiddy Dunigan has been listed as an employee of Foundation for Angelman Syndrome Therapeutics in Form 990 filings since fiscal year 2020. Total compensation for Maiddy Dunigan has decreased by 64.7% from 2020 to 2023.